Anagenics Limited (ASX: AN1) - Share Price
- Current share price for AN1 : $0.006
Anagenics Limited (AN1), an ASX-listed company, is a health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products.
AN1 General Information +
| ASX Code | AN1 |
| Website | http://www.anagenics.com |
| Industry/Sector | Personal Products |
| Market Cap ($M) | 5 |
| AN1 Share Price | $0.006 |
| Day High | $0.006 |
| Day Low | $0.006 |
| Last Close | $0.006 |
| AN1 Share Price Movement | - ( No change ) |
Prices as at 16:36, 22 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Anagenics Limited (AN1) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Anagenics Limited (AN1) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Anagenics Limited (AN1) price-sensitive announcements
AN1 - AN1 - Appendix 4C & Activity Report for Q3 FY2026
Anagenics Limited, trading as ASX: AN1, reported its Q3 FY2026 financial performance with
Anagenics Limited (AN1)
27 Apr 2026 | 10:31 AM
27 Apr 2026 | 10:31 AM
AN1 - Anagenics - 1H FY26 Result Highlights
Anagenics Limited announced its financial results for the first half of fiscal year 2026,
Anagenics Limited (AN1)
25 Feb 2026 | 8:48 AM
25 Feb 2026 | 8:48 AM
AN1 - Appendix 4D 1H FY26 DEC 2025
Anagenics Limited's Appendix 4D for the half year ended 31 December 2025 reports a signifi
Anagenics Limited (AN1)
25 Feb 2026 | 8:47 AM
25 Feb 2026 | 8:47 AM
AN1 - Appendix 4C & Activity Report for Q2 FY2026
Anagenics Limited, trading as ASX: AN1, reported significant improvements in their operati
Anagenics Limited (AN1)
29 Jan 2026 | 11:00 AM
29 Jan 2026 | 11:00 AM
Anagenics Limited (AN1) Recent ASX Announcements
AN1 Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2025A | -$0.90 | -$0.20 | -81.70% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$7.54 | -$1.00 | 447.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2023A | -$0.51 | -$0.20 | -88.10% | 0.00 | 0.00 | 0.00% | 0.0% |
AN1 Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | 2023 A | 2024 A | 2025 A | ||
| Anagenics Limited (AN1) | $6M | -0.8173 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
AN1 Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 1.62 | 0.00 |
| Market | 0.31 | 12.80 | 1.12 | 0.58 |
| Sector | 0.00 | 200.00 | 0.89 | 0.00 |
AN1 Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Scott Mitchell Greasley | Executive Director | 8 Jul 2022 |
| Mr Alexander (Sandy) Damien Harry Beard | Non-Executive Chairman, Non-Executive Director | 15 Feb 2022 |
| Mr Phillip Michael Christopher | Non-Executive Director | 5 Nov 2021 |
| Mr Joshua Gordon | Non-Executive Director | 2 Mar 2026 |
Anagenics Limited (AN1) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 26 Feb 2026 | BEARD, Alexander (Sandy) | Buy | Indirect Shares | 2,850,000 | $0.007 | $19,990.750 |
| 16 May 2025 | BEARD, Alexander (Sandy) | Buy | Indirect Shares | 55,564 | $0.006 | $336.320 |
| 14 May 2025 | BEARD, Alexander (Sandy) | Buy | Indirect Shares | 5 | $0.006 | $0.030 |
See all changes in directors' interest & trades for Anagenics Limited (AN1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
AN1 Management
| Name | Position |
|---|---|
| Hemant Amin | Company Secretary |
AN1 Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Anagenics Limited (AN1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 182,669,690 (36.80%) | HGL Limited |
| 35,000,000 (7.05%) | FOS Capital Limited |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
